Experts suggest that generative AI models in medicine should be licensed similarly to doctors and nurses to ensure accountability and safety.
Key Details
- 1Academic, policy, and public health leaders propose a licensure framework for medical GenAI models, similar to those for clinicians.
- 2UPenn's Eric Bressman and collaborators published a JAMA Internal Medicine opinion highlighting this approach.
- 3A blog post by UPenn policy expert Julia Hinkley supports a federal digital licensing board overseeing medical AI.
- 4FDA could handle premarket review, while state boards might provide ongoing oversight and coordinate standards.
- 5The initiative aims to address concerns about AI hallucinations, performance drift, and maintain standards and accountability.
Why It Matters
As generative AI’s use grows in radiology and other areas, robust and harmonized regulation is critical to maintain quality, safety, and trust. Introducing a licensing system modeled after medical professions could help set clear expectations and mechanisms for oversight of clinical AI systems.
Source
HealthExec
Related News
•Radiology Business
Radiology Partners Urges FDA for Clarity on Imaging AI Regulations
Radiology Partners and Mosaic Clinical Technologies petition the FDA for clearer regulatory guidelines on imaging AI vision-language models.
•Radiology Business
FDA Solicits Public Input on Regulating Generative AI in Medical Devices
The FDA is seeking public feedback on how to regulate generative AI in medical devices, recognizing both its promise and risks.
•HealthExec
AI's Role in Eliminating Cervical Cancer: A Model for Disease Prevention
Researchers highlight how AI can accelerate the elimination of cervical cancer and set a precedent for combating other diseases.